Advertisement
Clinical Therapeutics
Advanced searchSave search
Editorial| Volume 22, ISSUE 5, P639, May 2000

An outpatient prescription-medication benefit in medicare: So much time, so little consensus

DOI:https://doi.org/10.1016/S0149-2918(00)80050-8
An outpatient prescription-medication benefit in medicare: So much time, so little consensus
Previous ArticleEffects on serum lipid profiles of continuous 17β-estradiol, intermittent norgestimate regimens versus continuous combined 17β-estradiol/ norethisterone acetate hormone replacement therapy
Next ArticleThe effect of new and continuing prescription drug use on cost: A longitudinal analysis of chronic and seasonal utilization
      This paper is only available as a PDF. To read, Please Download here.

      References

        • Barrueta A
        Rhetoric, not solutions: Discussions over Medicare prescription drug benefits miss the point.
        Managed Health Care News. February 2000; : 46
        • Gullo K
        White House knocks GOP's Rx drug plan.
        Arizona Daily Star. April 21, 2000; : A12
        • McClellan M
        • Spatz ID
        • Carney S
        Designing a Medicare prescnption drug benefit: Issues, obstacles, and opportunities.
        Health Aff. 2000; 19: 26-41

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0149-2918(00)80050-8

      Copyright

      © 2000 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX